Evidence map›Paper›PMID 32587690›Full record

ArticleSAGE open medicine2020

Analysis of the impact of secondary prophylaxis on

Kathryn A Connor, Kelly M Conn

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in SAGE open medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06979609 (Secondary Prophylaxis of Recurrent Clostridioides Difficile Infections During Systemic Antibiotics With Vancomycin), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06979609 phase2 / phase3recruitingnot on this mapstarted 2025, after this paper: background citation

Secondary Prophylaxis of Recurrent Clostridioides Difficile Infections During Systemic Antibiotics With Vancomycin: A Randomized Controlled Trial

TypeinterventionalSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreRan2025 to 2029Enrolled300ConditionsClostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Clostridoides Difficile Associated DiseaseArmsOral Vancomycin Prophylaxis, Placebo
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Strategies to preventInfection control and hospital epidemiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kathryn A ConnorDepartment of Pharmacy Practice and Administration, Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-3755-5435
Kelly M ConnDepartment of Pharmacy Practice and Administration, Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY, USA.
St. John Fisher College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

objectivesTo determine whether critically ill adults receiving low-dose per os vancomycin for secondary

methodsThis was a retrospective, two-center, observational study in a large academic medical center and affiliated community hospital. Included patients had a history of

resultsEighty-two patients were included: 38 control (46.3%), 20 metronidazole (24.4%), 17 vancomycin (20.7%), and 7 combination (8.5%). Ten of 82 patients (12.2%) had at least one

conclusionThere was no difference in

Indexed as

Antibioticsclinical pharmacydiarrheaevidence-based practiceinfectious diseasesvancomycin

Identifiers

PMID32587690
PMCPMC7294487
OpenAlexW3035468078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.